Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European shares retreat from two-month highs as trade fuelled rally fades

Published 02/07/2019, 10:53
Updated 02/07/2019, 10:56
European shares retreat from two-month highs as trade fuelled rally fades

European shares retreat from two-month highs as trade fuelled rally fades

By Amy Caren Daniel

(Reuters) - European shares retreated on Tuesday from two-month highs hit in the previous session, as U.S.-China trade talk euphoria subsided and Washington's latest tariff threats on $4 billion (£3 billion) of additional EU goods held back market gains.

Days after reaching a truce in the U.S.-China trade war, the U.S. government on Monday ratcheted up pressure on Europe by releasing a list of additional products - including olives, Italian cheese and Scotch whiskey - that could be hit with tariffs.

Planemaker Airbus (PA:AIR) fell 0.6% as further tariff threats become the latest salvo in a long-running dispute over aircraft subsidies.

The pan-European STOXX 600 index (STOXX) rose 0.10% by 0706 GMT, with the trade-sensitive auto sector (SXAP) tumbling 0.72%.

"We've got the trade spat resurfacing between the U.S. and EU, which is reiterating Trump's protectionist stance on trade, and that is obviously not the kind of news you want to hear," said Florian Hense, European economist at Berenberg in London.

"The uncertainty about what could still come on trade causes confidence to fall and investors to hold back on their investment, which is a driver in markets today."

Global stock markets rallied on Monday, with the STOXX 50 index (STOXX50) hitting its highest level since February 2018, after the United States and China restarted trade negotiations over the weekend after a long pause.

The STOXX 600 index had its worst performance in more than two years in May after a sudden escalation in U.S.-China trade tensions, but stocks recouped most of their losses since then on hopes that major central banks would be more accommodative to counter the impact of the dispute.

However, U.S. President Donald Trump said on Monday that any trade deal with China would need to be "somewhat tilted" in favour of the United States putting a damper on sentiment.

The defensive healthcare sector took the lead in the main index, helped by Galapagos' shares (AS:GLPG), which jumped 6% after the drugmaker announced it would submit its drug filgotinib as a treatment for rheumatoid arthritis to the FDA this year.

Jupiter Fund Management (L:JUP) dropped 6.4% after the company said it is considering naming Devon Equity as an adviser for its European Opportunities Trust.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.